Guardian Pharmacy Services (NYSE:GRDN) reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it continued to offset profitability pressure from Inflation Reduction Act-related drug pricing reductions.
$GRDN
Price history, market instrument context, member research, and related headlines in one place.
GRDN key statistics
NYSEUSD
52-week range
$23.7269%$48.33
Latest session $39.30–$40.59Guardian Pharmacy Services, Inc. (GRDN) is a stock instrument quoted on NYSE in USD. The most recently published price is $40.58, up $0.77 (1.93%) from the previous close of $39.81. It has traded between $39.30 and $40.59 in the latest session. Over the past year it has ranged from $23.72 to $48.33, leaving it in the upper half of its 52-week range (69%). Reported volume for the session was 390.7K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Guardian Pharmacy Services Non-GAAP EPS of $0.29 beats by $0.03, revenue of $351.8M beats by $11.35M — See source for full details.
Loading $GRDN research…